Stockscreener 앱 받기
2.89
2.36%
-0.07
시간 외 거래:
2.85
-0.04
-1.38%
전일 마감가:
$2.96
열려 있는:
$2.985
하루 거래량:
12,100
Relative Volume:
0.47
시가총액:
$24.10M
수익:
$7.50M
순이익/손실:
$-9.85M
주가수익비율:
-2.0904
EPS:
-1.3825
순현금흐름:
$-24.56M
1주 성능:
-1.70%
1개월 성능:
-6.47%
6개월 성능:
-27.93%
1년 성능:
+6.25%
1일 변동 폭
$2.85
$3.0591
1주일 범위
$2.85
$3.15
52주 변동 폭
$2.45
$12.15
에바종 바이오테크 Stock (EVAX) Company Profile
Compare EVAX vs VRTX, REGN, ARGX, RVMD, ALNY
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
EVAX
Evaxion A S Adr
|
2.89 | 24.69M | 7.50M | -9.85M | -24.56M | -1.3825 |
VRTX
Vertex Pharmaceuticals Inc
|
479.00 | 121.16B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
667.17 | 68.78B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
888.82 | 57.44B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
188.07 | 40.23B | 742.00K | -1.37B | -1.07B | -7.0731 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.40 | 36.28B | 4.29B | 577.22M | 641.34M | 4.2086 |
에바종 바이오테크 Stock (EVAX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-02-19 | 개시 | Maxim Group | Buy |
| 2024-04-02 | 업그레이드 | Ladenburg Thalmann | Neutral → Buy |
| 2024-02-12 | 개시 | H.C. Wainwright | Buy |
에바종 바이오테크 주식(EVAX)의 최신 뉴스
Evaxion Biotech A/S Adr (EVAX) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1 - GlobeNewswire Inc.
European ADRs Rose As Biopharma Names Led The Pack - Finimize
US-Traded European Stocks Slipped As Arm And ArcelorMittal Fell - Finimize
Evaxion A/S Sponsored ADR Actuals & Estimates (NASDAQ:EVAX) - TradingView
European ADRs Edged Higher As Biotech Led Friday’s Moves - Finimize
Evaxion receives Prix Galien UK Award for Best digital health solution - Finansavisen
Evaxion presents new preclinical data for EVX-04, an off-the-shelf therapeutic vaccine for acute myeloid leukemia - Finansavisen
European ADRs Started The Week In The Green - Finimize
European ADRs Edged Higher In US Trading - Finimize
EVAXEvaxion A/S ADR Options - Finviz
Evaxion Biotech Signals Strong R&D Momentum Amid Cash Constraints - TipRanks
Evaxion promotes Birgitte Rønø to joint role of Chief Scientific and Chief Operating Officer - Finansavisen
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial - Finansavisen
Evaxion concludes Annual General Meeting - Finansavisen
Evaxion announces last patient visit in one-year extension of phase 2 trial with personalized cancer vaccine EVX-01 - Finansavisen
Endesa S.A. – Unsponsored ADR (OTCMKTS:ELEZY) Given Average Rating of “Strong Sell” by Brokerages - Defense World
Experience real-time quotes, in-depth charts, and analyst ratings - webull.com
Notice to convene Evaxion’s Annual General Meeting - Finansavisen
Europe’s US-Listed ADRs Rose, Led By Solar And Biotech - Finimize
European ADRs Rose, While Biotech Names Did The Heavy Lifting - Finimize
Evaxion Biotech Earnings Call Highlights AI and Runway - TipRanks
Evaxion A/S (NASDAQ:EVAX) Receives Buy Rating from HC Wainwright - Defense World
Evaxion A/S (NASDAQ:EVAX) Price Target Cut to $9.00 by Analysts at Lake Street Capital - Defense World
Evaxion Earnings Report: Q4 Overview - Sahm
Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Short Interest Up 20.9% in February - Defense World
Evaxion Biotech's Earnings: A Preview - Sahm
European ADRs Slip Slightly As Winners And Losers Split - Finimize
Brokerages Set Evaxion A/S – Sponsored ADR (NASDAQ:EVAX) Target Price at $12.33 - Defense World
European ADRs Edge Higher Despite Mixed Stock Moves - Finimize
Biotech Stocks Lead European ADRs Higher On Wall Street - Finimize
European Biotech Stocks Outperformed As Broader Market Dipped - Finimize
European Pharma And Biotech Companies Led ADR Gains In The US - Finimize
Analysts Are Bullish on Top Healthcare Stocks: Evaxion Biotech (EVAX), Azitra Inc (AZTR) - The Globe and Mail
Evaxion Stock Climbs Amid Biotech Surge - StocksToTrade
Evaxion Biotech A/S Announces Change in American Depositary Shares Ratio to Enhance Liquidity - nasdaq.com
Evaxion A/S (EVAX) Stock Forecast and Price Target 2026 - MarketBeat
Why Is Cancer Therapy Focused Evaxion Biotech Stock Trading Higher Today? - Sahm
symbol__ Stock Quote Price and Forecast - CNN
Evaxion (EVAX) Up on Partnership With Afrigen for Gonorrhea Jab - Nasdaq
Evaxion Biotech (EVAX) Profile, Company FAQs & Facts, Industry, Sector, Employee Strength - Stocktwits
What is the current Price Target and Forecast for Evaxion A/SSponsored ADR (EVAX) - Zacks Investment Research
Top movers in Friday's pre-market session - ChartMill
에바종 바이오테크 (EVAX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.97%
0.83%
자본화:
|
볼륨(24시간):